Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

70.43
Delayed Data
As of 4:02pm ET
 -1.46 / -2.03%
Today’s Change
66.93
Today|||52-Week Range
83.58
-3.31%
Year-to-Date
Mallinckrodt Hit With $100M Fine for Squelching Rival to Infant Seizure Drug
Jan 18 / TheStreet.com - Paid Partner Content
4 Signs Glaxo's Turnaround Is Taking Hold
Jan 13 / MotleyFool.com - Paid Partner Content
Watch Point Trust Co Buys Comcast Corp, Newell Brands Inc, Novartis AG, Sells Abbott ...
Jan 18 / GuruFocus News - Paid Partner Content
ARIAD: Acquisition by Takeda Bodes Well, Competition a Risk
Jan 13 / Zacks.com - Paid Partner Content
Why Bristol-Myers Squibb May Be a Merger Target Soon
Jan 17 / TheStreet.com - Paid Partner Content
Short Interest In Conatus Pharmaceuticals Surges
Jan 13 / Benzinga - Paid Partner Content
Novartis to Conduct Trial on Obese, Type II Diabetes Patients
Jan 13 / Zacks.com - Paid Partner Content
Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit
Jan 13 / Zacks.com - Paid Partner Content
Why Juno Therapeutics Crashed 57.1% in 2016 and What's Next
Jan 13 / MotleyFool.com - Paid Partner Content
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
Jan 11 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close71.89
Today’s open70.49
Day’s range70.23 - 70.88
Volume5,658,287
Average volume (3 months)2,995,432
Market cap$167.1B
Dividend yield3.86%
Data as of 4:02pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+77.51%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-4.75%
P/E ratio24.8
Price/Sales4.25
Price/Book2.22

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.84-1.37%
PFEPfizer-0.33-1.03%
SNYSanofi-0.59-1.45%
ABBVAbbVie-0.28-0.45%
Data as of 4:01pm ET, 01/19/2017

Financials

Next reporting dateJanuary 25, 2017
EPS forecast (this quarter)$1.12
Annual revenue (last year)$49.4B
Annual profit (last year)$17.8B
Net profit margin14.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts


Search for Jobs